Feb. 13, 2018: 1 p.m. - 1:55 p.m.
As the scientific challenges of developing new and superior treatments increase in difficulty, corporate management’s ability to maximize the capacity of their teams to innovate becomes ever more urgent. Recent research in cognitive science and comparative stock investment results suggest clear performance advantages that more highly diversified teams and boards can deliver. Traditional recruitment processes for corporate executive teams often fail to reflect the employee bases they lead or patient populations they serve. This session will focus on practical approaches and successful examples to diversify leadership recruitment efforts, create inclusive cultures for development/retention, and better align organizations with the full measure of talented people available.
Moderator: James Sapirstein, RPh, Chief Executive Officer, ContraVir
Karen Anderson, Senior Vice President, Chief Human Resources Officer, Alnylam Pharmaceuticals
Wanda Bryant Hope, Chief Diversity & Inclusion Officer, Johnson & Johnson
Sabrina Martucci Johnson, President and Chief Executive Officer, Daré Bioscience, Inc.